Roche Hit With $25M Accutane Verdict

By Ben James

Law360, New York (February 17, 2010, 6:52 PM ET) -- A New Jersey state court jury has smacked drugmaker Hoffmann-La Roche Inc. with a $25.2 million dollar verdict in a case brought by a man who claimed the acne drug Accutane was responsible for the inflammatory bowel disease that led to the loss of his colon.

The verdict came down Tuesday in the New Jersey Superior Court and followed a five-week trial and about three and a half days of jury deliberation, according to Michael Hook, who represents plaintiff and former Accutane user Andrew McCarrell....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles